Company backs guidance despite impairment
- British American Tobacco expects a one-off impairment of around GBP25 billion in 2023
- The company backs its full-year guidance
- 2023 revenue growth expected to be at the low end of the previously guided range
British American Tobacco has announced that it expects a one-off impairment of around GBP25 billion in 2023. Despite this, the company is still backing its full-year guidance. However, it anticipates that its 2023 revenue growth will be at the low end of the previously guided range of 3% to 5% at constant currency.
Factuality Level: 7
Factuality Justification: The article provides information about British American Tobacco’s expected one-off impairment in 2023 and its revenue growth projection for the same year. The information seems to be based on the company’s statement. However, the article lacks in-depth analysis and context, and it does not provide any additional sources or perspectives. Therefore, while the basic facts may be accurate, the article’s overall factuality level is reduced due to its limited scope and lack of supporting information.
Noise Level: 3
Noise Justification: The article provides some relevant information about British American Tobacco’s decrease in value and its one-off impairment in 2023. However, it lacks in-depth analysis, evidence, and actionable insights. It also does not explore the consequences of these developments on the company or its stakeholders.
Financial Relevance: Yes
Financial Markets Impacted: British American Tobacco (BTI) may be impacted
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article discusses a decrease in British American Tobacco’s stock and a one-off impairment expected in 2023. However, there is no mention of an extreme event or its impact rating.
Public Companies: British American Tobacco (BTI)
Key People:
Reported publicly:
www.wsj.com 
